C
Cannara Biotech Inc. LOVFF
$1.34 -$0.02-1.47% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

05/31/2025 02/28/2025 11/30/2024 08/31/2024 05/31/2024
Net Income 98.41% 190.28% 8.60% 20.91% -31.21%
Total Depreciation and Amortization -18.99% 5.54% -4.60% 30.69% 17.73%
Total Amortization of Deferred Charges -- -- -- -92.29% --
Total Other Non-Cash Items 224.74% -73.39% 40.32% -145.28% -54.12%
Change in Net Operating Assets 173.72% -1,764.72% 108.08% 106.06% 437.50%
Cash from Operations 211.50% -186.62% 639.66% 7.39% 69.50%
Capital Expenditure 30.62% -23.18% 56.44% 73.04% -19.09%
Sale of Property, Plant, and Equipment -99.27% -- -38.89% -90.31% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 36.27% 52.89% 11.41% -5.16% 22.94%
Cash from Investing -119.28% -21.95% 57.37% 73.76% 63.08%
Total Debt Issued -- -- -80.00% -100.00% 46.67%
Total Debt Repaid 44.70% 71.02% -14.92% -9.79% -415.24%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- 100.00% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -217.13% 32.83% 33.64% 43.29% 73.22%
Cash from Financing -123.32% 1.27% -417.61% -51.08% -869.23%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 288.39% -1,094.99% 321.53% 363.79% 2,165.86%